ClassID:

93275

C07C291/04 - CPC Classification

Classification description:

Compounds containing carbon and nitrogen and having functional groups not covered by groups  -  containing nitrogen-oxide bonds containing amino-oxide bonds

Recent Application in this class:
#1
20250388534
2025-12-25

SUPRAMOLECULAR TRANEXAMIC ACID-MANDELIC ACID IONIC SALT AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF

#2
20250313527
2025-10-09

AMPHIPHILIC LIPID INCLUDING TERTIARY AMINE N-OXIDE GROUP, LIPOSOMAL DRUG-DELIVERY SYSTEM, AND USE OF AMPHIPHILIC LIPID

#3
20240360073
2024-10-31

BENZOATE DERIVATIVES

#4
20240208898
2024-06-27

ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS

#5
20240124390
2024-04-18

Benzoate derivatives

#6
20230295072
2023-09-21

Fluorinated phenylamino compounds and pharmaceutical compositions

#7
20230174460
2023-06-08

AFMT ANALOGS AND THEIR USE IN METHODS OF TREATING PARKINSON'S DISEASE

#8
20230100647
2023-03-30

COMPOSITION AND METHOD FOR PRODUCING SAME

#9
20210230107
2021-07-29

Amino acid surfactants

#10
20200270200
2020-08-27

Deuterated compounds and uses thereof

#11
20200002275
2020-01-02

Dimethyl Farnesyl Amine Oxide And Its Use As Surfactant Or Wetting Agent

#12
20200000794
2020-01-02

BENZOQUINOLONE INHIBITORS OF VMAT2

#13
20190336462
2019-11-07

USE OF HYDROGEN SULFIDE SYNTHESIS INHIBITORS FOR CANCER THERAPY

#14
20190300493
2019-10-03

Production of an amine oxide by oxidation of a tertiary amine

#15
20190292129
2019-09-26

Twin tail amine compounds and their zwitterionic derivatives

#16
20190218171
2019-07-18

Branched trialkyl quaternary ammonium compounds

#17
20190218169
2019-07-18

Branched trialkyl amine oxides

#18
20190185413
2019-06-20

BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF

#19
20190023709
2019-01-24

SHIP1 MODULATORS AND METHODS RELATED THERETO

#20
20180334516
2018-11-22

Regulators for controlling linear and pseudo-ring expansion polymerization of vinyl monomers

#21
20180297935
2018-10-18

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

#22
20180294396
2018-10-11

N-type thermoelectric conversion layer, thermoelectric conversion element, and composition for forming N-type thermoelectric conversion layer

#23
20170362166
2017-12-21

β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof

#24
20170246159
2017-08-31

BENZOQUINOLONE INHIBITORS OF VMAT2

#25
20170065726
2017-03-09

Crosslinking reagents, macromolecules, therapeutic bioconjugates, and synthetic methods thereof

#26
20170036992
2017-02-09

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

#27
20160214933
2016-07-28

Amine mining collectors

#28
20160095831
2016-04-07

Use of hydrogen sulfide synthesis inhibitors for cancer therapy

#29
20160030414
2016-02-04

BENZOQUINOLINE INHIBITORS OF VMAT 2

#30
20150307441
2015-10-29

Deuterated compounds and uses thereof

#31
20140249161
2014-09-04

Stilbene analogs and methods of treating cancer

#32
20140206903
2014-07-24

Crosslinking reagents, macromolecules, therapeutic conjugates, and synthetic methods thereof

#33
20140031591
2014-01-30

Continuous process to make amine oxide

#34
20140014330
2014-01-16

Methods for treating siliciclastic hydrocarbon-bearing formations with fluorinated amine oxides

#35
20130274283
2013-10-17

Premature-termination-codons readthrough compounds

#36
20120302792
2012-11-29

Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process of making reaction products from cyclic α, β-unsaturated ketone substrates and nitroso substrates

#37
20120196874
2012-08-02

Stilbene analogs and methods of treating cancer

#38
20120003330
2012-01-05

BENZOQUINOLONE INHIBITORS OF VMAT2

#39
20110318417
2011-12-29

HIGHLY PURE CINACALCET OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

#40
20110312903
2011-12-22

Fluorination of organic compounds

#41
20110263699
2011-10-27

1-Phenyl-2-DimethylaminomethylCyclohexane Compounds and Therapies for Depressive Symptoms, Pain and Incontinence

#42
20110207964
2011-08-25

Process for producing nitrogen-containing compounds

#43
20110124782
2011-05-26

Fluorinated ether compounds and methods of using the same

#44
20110034363
2011-02-10

Specific branched surfactants and consumer products

#45
20100113807
2010-05-06

Solid phase reaction system for oxidation

#46
20100099915
2010-04-22

Process of making alpha-aminooxyketone/alpha-aminooxyaldehyde and alpha-hydroxyketone/alpha-hydroxyaldehyde compounds and a process making reaction products from cyclic alpha, beta-unsaturated ketone substrates and nitroso substrates

#47
20100016252
2010-01-21

Mannich base N-oxide drugs

#48
20090318509
2009-12-24

Oxime Derivatives as Inhibitors of Macrophage Migration Inhibitory Factor

#49
20090318454
2009-12-24

NOVEL ANTIOXIDANTS AND METHODS OF TREATMENT

#50
20090209018
2009-08-20

Catalase decomposition of hydrogen peroxide in surfactants

#51
20090139618
2009-06-04

N-hydroxy-N'-nitrourea and related compounds as high energy density materials

#52
20090069449
2009-03-12

Ethambutol based nitric oxide donors

#53
20090005455
2009-01-01

N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs

#54
20080305082
2008-12-11

1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof

#55
20080261895
2008-10-23

Isolated hydroxy and n-oxide metabolites and derivatives of O-desmethylvenlafaxine and methods of treatment

#56
20080220496
2008-09-11

Catalase decomposition of hydrogen peroxide in surfactants

#57
20080182824
2008-07-31

MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesity

#58
20080097061
2008-04-24

Oxylamino group-containing compound and polymer

#59
20070161808
2007-07-12

Process for the preparation of aq4n

#60
20070037973
2007-02-15

Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process making reaction products from cyclic α,β-unsaturated ketone substrates and nitroso substrates

#61
20070004701
2007-01-04

Topoisomerase inhibitors

#62
20060205820
2006-09-14

Formulations of anthraquinone derivatives

#63
20060180794
2006-08-17

Polyamine-based corrosion inhibitors

#64
20060106255
2006-05-18

Process of making long chain internal fatty tertiary amines

#65
20060084828
2006-04-20

Process for preparation of (+)-p-mentha-2,8-diene-1-ol

#66
20050256188
2005-11-17

Formulations of anthraquinone derivatives

#67
20050253415
2005-11-17

Vehicle and a vehicle door

#68
20050182131
2005-08-18

1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence

#69
20050176766
2005-08-11

2,3-Oxidosqualene-lanosterol cyclase inhibitors

#70
20050165044
2005-07-28

Fused ring dicationic anti-protozoan agents and their prodrugs

#71
20050124691
2005-06-09

Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same